RESEARCH AND DEVELOPMENT

Currently, Matrix Biomed, Inc. gene-based therapeutics has produced drug products with two main objectives : 1) increase the efficacy of current cancer treatment regimens and 2) decrease side effects of chemotherapy and radiation. By targeting the master genes responsible for cancer development and progression (HIF-1 and HIF-2), Matrix Biomed, Inc. is poised to transform cancer treatment.